Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · IEX Real-Time Price · USD
19.37
-0.85 (-4.20%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Pacira BioSciences Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$46.10
Upside
+138.00%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $42 | Buy | Maintains | $42 | +116.83% | Jul 3, 2024 |
| Barclays | Barclays | Buy → Hold Downgrades $38 → $25 | Buy → Hold | Downgrades | $38 → $25 | +29.07% | Jul 3, 2024 |
| Needham | Needham | Strong Buy Reiterates $43 | Strong Buy | Reiterates | $43 | +121.99% | Jul 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +194.27% | Jul 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +194.27% | May 8, 2024 |
| Barclays | Barclays | Buy Maintains $40 → $38 | Buy | Maintains | $40 → $38 | +96.18% | May 8, 2024 |
| Needham | Needham | Strong Buy Maintains $45 → $43 | Strong Buy | Maintains | $45 → $43 | +121.99% | May 8, 2024 |
| Needham | Needham | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +132.32% | Apr 9, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $45 | Buy | Initiates | $45 | +132.32% | Mar 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +194.27% | Mar 4, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $53 → $45 | Buy | Maintains | $53 → $45 | +132.32% | Mar 1, 2024 |
| Needham | Needham | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +132.32% | Mar 1, 2024 |
| Wedbush | Wedbush | Buy Reiterates $57 | Buy | Reiterates | $57 | +194.27% | Feb 8, 2024 |
| Raymond James | Raymond James | Buy Initiates $42 | Buy | Initiates | $42 | +116.83% | Dec 20, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $63 → $57 | Strong Buy | Maintains | $63 → $57 | +194.27% | Nov 6, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $50 → $42 | Buy | Maintains | $50 → $42 | +116.83% | Nov 3, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $67 → $58 | Buy | Maintains | $67 → $58 | +199.43% | Nov 3, 2023 |
| Needham | Needham | Strong Buy Maintains $52 → $45 | Strong Buy | Maintains | $52 → $45 | +132.32% | Nov 3, 2023 |
| Barclays | Barclays | Buy Maintains $60 → $57 | Buy | Maintains | $60 → $57 | +194.27% | Oct 23, 2023 |
| RBC Capital | RBC Capital | Buy Reiterates $68 | Buy | Reiterates | $68 | +251.06% | Oct 3, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $60 → $50 | Buy | Maintains | $60 → $50 | +158.13% | Aug 3, 2023 |